Tff Pharmaceuticals Stock Alpha and Beta Analysis

TFFP Stock  USD 0.34  0.03  9.68%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Tff Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Tff Pharmaceuticals over a specified time horizon. Remember, high Tff Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Tff Pharmaceuticals' market risk premium analysis include:
Beta
1.28
Alpha
(1.58)
Risk
12.36
Sharpe Ratio
(0.11)
Expected Return
(1.33)
Please note that although Tff Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Tff Pharmaceuticals did 1.58  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Tff Pharmaceuticals stock's relative risk over its benchmark. Tff Pharmaceuticals has a beta of 1.28  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tff Pharmaceuticals will likely underperform. At this time, Tff Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 11/30/2024, Price Fair Value is likely to grow to 1.38, while Book Value Per Share is likely to drop 5.07.

Enterprise Value

6.86 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Tff Pharmaceuticals Backtesting, Tff Pharmaceuticals Valuation, Tff Pharmaceuticals Correlation, Tff Pharmaceuticals Hype Analysis, Tff Pharmaceuticals Volatility, Tff Pharmaceuticals History and analyze Tff Pharmaceuticals Performance.
To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.

Tff Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Tff Pharmaceuticals market risk premium is the additional return an investor will receive from holding Tff Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tff Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Tff Pharmaceuticals' performance over market.
α-1.58   β1.28

Tff Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Tff Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Tff Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Tff Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Tff Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tff Pharmaceuticals shares will generate the highest return on investment. By understating and applying Tff Pharmaceuticals stock market price indicators, traders can identify Tff Pharmaceuticals position entry and exit signals to maximize returns.

Tff Pharmaceuticals Return and Market Media

The median price of Tff Pharmaceuticals for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 1.96 with a coefficient of variation of 36.28. The daily time series for the period is distributed with a sample standard deviation of 0.65, arithmetic mean of 1.78, and mean deviation of 0.46. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment
09/11/2024
2
Acquisition by Rocamboli Stephen of 3165 shares of Tff Pharmaceuticals subject to Rule 16b-3
10/15/2024
3
ARMISTICE CAPITAL, LLC Acquires Shares in TFF Pharmaceuticals Inc
11/15/2024
4
TFF Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
11/20/2024

About Tff Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Tff or other stocks. Alpha measures the amount that position in Tff Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2010 2023 2024 (projected)
Dividend Yield0.02370.02130.019
Price To Sales Ratio17.1515.4313.72

Tff Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of Tff Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tff Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Tff Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Tff Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Tff Pharmaceuticals' management manipulating its earnings.
13th of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Tff Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Tff Stock Analysis

When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.